Prognostic Impact of Vitamin B6 Metabolism in Lung Cancer

Cell Reports

Volumn 2, Issue 2, 2012, Pages 257-269

  Galluzzi, Lorenzo ^a,b,c   Vitale, Ilio ^a,b,c   Senovilla, Laura ^a,b,c   Olaussen, Ken André ^a,b,c   Pinna, Guillaume ^c,d   Eisenberg, Tobias ^e   Goubar, Aïcha ^a,b,c   Martins, Isabelle ^a,b,c   Michels, Judith ^a,b,c   Kratassiouk, Gueorgui ^c,d   Carmona Gutierrez, Didac ^e   Scoazec, Marie ^b   Vacchelli, Erika ^a,b,c   Schlemmer, Frederic ^a,b,c   Kepp, Oliver ^a,b,c   Shen, Shensi ^a,b,c   Tailler, Maximilien ^a,b,c   Niso Santano, Mireia ^a,b,c   Morselli, Eugenia ^a,b,c   Criollo, Alfredo ^a,b,c   Adjemian, Sandy ^a,b,c   Jemaà, Mohamed ^a,b,c   Chaba, Kariman ^a,b   Pailleret, Claire ^a,b,c   Michaud, Mickaël ^a,b,c   Pietrocola, Federico ^a,b,c   Tajeddine, Nicolas ^a,b,c   de La Motte Rouge, Thibault ^f   Araujo, Natalia ^c,d   Morozova, Nadya ^c,d   Robert, Thomas ^b   Ripoche, Hugues ^b,g   Commo, Frederic ^a,b,c   Besse, Benjamin ^b   Validire, Pierre ^h   Fouret, Pierre ^a,f,i   Robin, Angélique ^a,b,c   Dorvault, Nicolas ^a,b,c   Girard, Philippe ^h   Gouy, Sébastien ^b   Pautier, Patricia ^b   Jägemann, Nora ^j   Nickel, Ann Christin ^k   Marsili, Sabrina ^l   Paccard, Caroline ^m,n,o   Servant, Nicolas ^m,n,o   Hupé, Philippe ^d,m,n,o   Behrens, Carmen ^p   Behnam Motlagh, Parviz ^q   Kohno, Kimitoshi ^r   Cremer, Isabelle ^s   Damotte, Diane ^t   Alifano, Marco ^u   Midttun, Øivind ^v   Ueland, Per Magne ^w   Lazar, Vladimir ^b   Dessen, Philippe ^a,b   Zischka, Hans ^j   Chatelut, Etienne ^l   Castedo, Maria ^a,b,c   Madeo, Frank ^e   Barillot, Emmanuel ^m,n,o   Thomale, Juergen ^k   Wistuba, Ignacio Ivan ^p   Sautès Fridman, Catherine ^a,s,t   Zitvogel, Laurence ^a,b   Soria, Jean Charles ^a,b,c   Harel Bellan, Annick ^c,d   Kroemer, Guido ^a,b,s,t,x   more..

^a INSERM   (France)

^b INSTITUT GUSTAVE ROUSSY   (France)

^c UNIVERSITÉ PARIS SACLAY   (France)

^d CNRS   (France)

^e UNIVERSITY OF GRAZ   (Austria)

^f PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^g Gustave Roussy Comprehensive Cancer Institute   (France)

^h INSTITUT MUTUALISTE MONTSOURIS   (France)

ⁱ SORBONNE UNIVERSITÉ   (France)

^j INSTITUTE OF EPIDEMIOLOGY   (Germany)

^k UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^l INSTITUT CLAUDIUS REGAUD   (France)

^m INSTITUT CURIE   (France)

ⁿ INSERM U900   (France)

^o PSL RESEARCH UNIVERSITY   (France)

^p UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^q UMEÅ UNIVERSITY   (Sweden)

^r UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^s CENTRE DE RECHERCHE DES CORDELIERS   (France)

^t UNIVERSITÉ PARIS DESCARTES   (France)

^u HÔTEL DIEU   (France)

^v BEVITAL AS   (Norway)

^w UNIVERSITY OF BERGEN   (Norway)

^x HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; GLUTATHIONE; PYRIDOXAL KINASE; PYRIDOXINE; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BIOENERGY; CANCER CELL; CANCER PROGNOSIS; CHEMICAL STRESS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; DNA DAMAGE; DRUG RESPONSE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; PHYSICAL STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; RISK ASSESSMENT; SENSITIZATION; STRESS; VITAMIN METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CISPLATIN; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LUNG NEOPLASMS; MALE; MICE; MIDDLE AGED; NEOPLASM PROTEINS; PYRIDOXAL KINASE; SURVIVAL RATE; VITAMIN B 6;

EID: 84865704717     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2012.06.017     Document Type: Article

References (43)

1. Alavian K.N., Li H., Collis L., Bonanni L., Zeng L., Sacchetti S., Lazrove E., Nabili P., Flaherty B., Graham M., et al. Bcl-xL regulates metabolic efficiency of neurons through interaction with the mitochondrial F1FO ATP synthase. Nat. Cell Biol. 2011, 13:1224-1233.
2. Anastasiou D., Poulogiannis G., Asara J.M., Boxer M.B., Jiang J.K., Shen M., Bellinger G., Sasaki A.T., Locasale J.W., Auld D.S., et al. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
3. Atkinson D.E. The energy charge of the adenylate pool as a regulatory parameter. Interaction with feedback modifiers. Biochemistry 1968, 7:4030-4034.
4. Bossenmeyer-Pourié C., Kannan R., Ribieras S., Wendling C., Stoll I., Thim L., Tomasetto C., Rio M.C. The trefoil factor 1 participates in gastrointestinal cell differentiation by delaying G1-S phase transition and reducing apoptosis. J. Cell Biol. 2002, 157:761-770.
5. Brown C.J., Lain S., Verma C.S., Fersht A.R., Lane D.P. Awakening guardian angels: drugging the p53 pathway. Nat. Rev. Cancer 2009, 9:862-873.
6. Buchakjian M.R., Kornbluth S. The engine driving the ship: metabolic steering of cell proliferation and death. Nat. Rev. Mol. Cell Biol. 2010, 11:715-727.
7. Castedo M., Coquelle A., Vivet S., Vitale I., Kauffmann A., Dessen P., Pequignot M.O., Casares N., Valent A., Mouhamad S., et al. Apoptosis regulation in tetraploid cancer cells. EMBO J. 2006, 25:2584-2595.
8. Cosaert J., Quoix E. Platinum drugs in the treatment of non-small-cell lung cancer. Br. J. Cancer 2002, 87:825-833.
9. de La Motte Rouge T., Galluzzi L., Olaussen K.A., Zermati Y., Tasdemir E., Robert T., Ripoche H., Lazar V., Dessen P., Harper F., et al. A novel epidermal growth factor receptor inhibitor promotes apoptosis in non-small cell lung cancer cells resistant to erlotinib. Cancer Res. 2007, 67:6253-6262.
10. Galluzzi L., Zamzami N., de La Motte Rouge T., Lemaire C., Brenner C., Kroemer G. Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis 2007, 12:803-813.
11. Galluzzi L., Vitale I., Kepp O., Séror C., Hangen E., Perfettini J.L., Modjtahedi N., Kroemer G. Methods to dissect mitochondrial membrane permeabilization in the course of apoptosis. Methods Enzymol. 2008, 442:355-374.
12. Galluzzi L., Aaronson S.A., Abrams J., Alnemri E.S., Andrews D.W., Baehrecke E.H., Bazan N.G., Blagosklonny M.V., Blomgren K., Borner C., et al. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009, 16:1093-1107.
13. Galluzzi L., Morselli E., Vitale I., Kepp O., Senovilla L., Criollo A., Servant N., Paccard C., Hupé P., Robert T., et al. miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res. 2010, 70:1793-1803.
14. Gil J., Peters G. Regulation of the INK4b-ARF-INK4a tumour suppressor locus: all for one or one for all. Nat. Rev. Mol. Cell Biol. 2006, 7:667-677.
15. Gyrd-Hansen M., Meier P. IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer. Nat. Rev. Cancer 2010, 10:561-574.
16. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
18. Harris H.R., Cramer D.W., Vitonis A.F., Depari M., Terry K.L. Folate, vitamin B(6), vitamin B(12), methionine and alcohol intake in relation to ovarian cancer risk. Int. J. Cancer 2011, 131:E518-E529.
19. Iwahara T., Fujimoto J., Wen D., Cupples R., Bucay N., Arakawa T., Mori S., Ratzkin B., Yamamoto T. Molecular characterization of ALK, a receptor tyrosine kinase expressed specifically in the nervous system. Oncogene 1997, 14:439-449.
20. Jemal A., Thun M.J., Ries L.A., Howe H.L., Weir H.K., Center M.M., Ward E., Wu X.C., Eheman C., Anderson R., et al. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J. Natl. Cancer Inst. 2008, 100:1672-1694.
21. Johansson M., Relton C., Ueland P.M., Vollset S.E., Midttun O., Nygård O., Slimani N., Boffetta P., Jenab M., Clavel-Chapelon F., et al. Serum B vitamin levels and risk of lung cancer. JAMA 2010, 303:2377-2385.
22. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
23. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
24. Larsson S.C., Orsini N., Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 2010, 303:1077-1083.
25. Lee H.S., Moon B.J., Choi S.Y., Kwon O.S. Human pyridoxal kinase: overexpression and properties of the recombinant enzyme. Mol. Cells 2000, 10:452-459.
26. Lodi A., Ronen S.M. Magnetic resonance spectroscopy detectable metabolomic fingerprint of response to antineoplastic treatment. PLoS ONE 2011, 6:e26155.
27. Midttun O., Hustad S., Ueland P.M. Quantitative profiling of biomarkers related to B-vitamin status, tryptophan metabolism and inflammation in human plasma by liquid chromatography/tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2009, 23:1371-1379.
28. Morris S.W., Kirstein M.N., Valentine M.B., Dittmer K.G., Shapiro D.N., Saltman D.L., Look A.T. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994, 263:1281-1284.
29. Ni Chonghaile T., Sarosiek K.A., Vo T.T., Ryan J.A., Tammareddi A., Moore Vdel.G., Deng J., Anderson K.C., Richardson P., Tai Y.T., et al. Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy. Science 2011, 334:1129-1133.
30. Percudani R., Peracchi A. A genomic overview of pyridoxal-phosphate-dependent enzymes. EMBO Rep. 2003, 4:850-854.
31. Previati M., Lanzoni I., Corbacella E., Magosso S., Guaran V., Martini A., Capitani S. Cisplatin-induced apoptosis in human promyelocytic leukemia cells. Int. J. Mol. Med. 2006, 18:511-516.
32. Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., et al. Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer. Cell 2007, 131:1190-1203.
33. Seth R., Yang C., Kaushal V., Shah S.V., Kaushal G.P. p53-dependent caspase-2 activation in mitochondrial release of apoptosis-inducing factor and its role in renal tubular epithelial cell injury. J. Biol. Chem. 2005, 280:31230-31239.
34. Sève P., Dumontet C. Chemoresistance in non-small cell lung cancer. Curr. Med. Chem. Anticancer Agents 2005, 5:73-88.
35. Stoica G.E., Kuo A., Powers C., Bowden E.T., Sale E.B., Riegel A.T., Wellstein A. Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types. J. Biol. Chem. 2002, 277:35990-35998.
36. Streit M., Riccardi L., Velasco P., Brown L.F., Hawighorst T., Bornstein P., Detmar M. Thrombospondin-2: a potent endogenous inhibitor of tumor growth and angiogenesis. Proc. Natl. Acad. Sci. USA 1999, 96:14888-14893.
37. Tajeddine N., Galluzzi L., Kepp O., Hangen E., Morselli E., Senovilla L., Araujo N., Pinna G., Larochette N., Zamzami N., et al. Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death. Oncogene 2008, 27:4221-4232.
38. Tesniere A., Schlemmer F., Boige V., Kepp O., Martins I., Ghiringhelli F., Aymeric L., Michaud M., Apetoh L., Barault L., et al. Immunogenic death of colon cancer cells treated with oxaliplatin. Oncogene 2010, 29:482-491.
39. Vitale I., Galluzzi L., Vivet S., Nanty L., Dessen P., Senovilla L., Olaussen K.A., Lazar V., Prudhomme M., Golsteyn R.M., et al. Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway. PLoS ONE 2007, 2:e1337.
40. Vitale I., Senovilla L., Galluzzi L., Criollo A., Vivet S., Castedo M., Kroemer G. Chk1 inhibition activates p53 through p38 MAPK in tetraploid cancer cells. Cell Cycle 2008, 7:1956-1961.
41. Vousden K.H., Ryan K.M. p53 and metabolism. Nat. Rev. Cancer 2009, 9:691-700.
42. Ward P.S., Thompson C.B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell 2012, 21:297-308.
43. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.